Core Viewpoint - Picard Medical, Inc. is enhancing the SynCardia Total Artificial Heart design by incorporating CPC "Connector Covers" to improve patient comfort and reinforce device safety and reliability [1][2]. Company Overview - Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, which is based in Tucson, Arizona. It is the leader in total artificial heart technology for patients with end-stage heart failure [4]. - The SynCardia Total Artificial Heart (STAH) is the first artificial heart approved by both the FDA and Health Canada, and it remains the only commercially available artificial heart in the United States and Canada [4]. - Over 2,100 implants of the STAH have been performed in hospitals across 27 countries, making it the most widely used and extensively studied artificial heart globally [4]. Product Enhancement - The CPC Connector Covers will provide an additional layer of protection over the metal release buttons on the STAH CPC connectors, which connect SynCardia Drivers to the pneumatic drive cannulas of the STAH ventricles [2]. - The rollout of this enhancement is expected to begin in standard clinical practice for patients in the U.S. on January 15, 2026 [2]. Commitment to Patient Safety - The company emphasizes that patient safety and quality of life are central to its operations, reflecting a commitment to practical improvements that enhance confidence and ease of use for both patients and clinicians [3]. - All SynCardia sales and clinical staff have completed the necessary training ahead of the rollout, and the company will provide training materials and support to hospital and clinical teams [3].